• Analyst Update
Goldman: Sell This Biotech Stock Now
The brokerage firm set a Street-low price target on the Inbrija parent
December 11, 2018 11:33 AM
  • Analyst Update
Weight Watchers a 'Buy' Before Diet Season, Says Analyst
DA Davidson: The NutriSystem deal shows WTW is undervalued
December 11, 2018 11:28 AM
  • Quantitative Analysis
  • Indexes and ETFs
  • Editor's Pick
Worst December Start for Stocks Since 1980
However, don't give up hope for a Santa Claus rally
December 11, 2018 10:53 AM
  • Options Recommendations
Buying Opportunity as Yum! Brands Stock Bounces from Support
The shares have found support at their 80-day trendline and +10% YTD return
December 11, 2018 10:24 AM
  • Analyst Update
Analyst Targets 36% Upside for CVS Health Stock
The brokerage firm initiated coverage with an "outperform" rating
December 11, 2018 10:02 AM
  • Indicator of the Week
Best Time to Buy Stocks in December
December is historically a bullish month for stocks
November 27, 2018 4:41 PM
  • Analyst Update
More Skepticism for Travelers Stock as RBC Cuts Rating
TRV's 200-day moving average has been resistance for months
December 11, 2018 9:40 AM
  • Buzz Stocks
  • Analyst Update
Biotech Stock Primed for Best Day Ever After Amgen Deal
ENTX is on track to trade near its late-October highs
December 11, 2018 9:22 AM
  • Opening View
Dow Futures Pop as U.S., China Move Forward on Trade
Trump tweeted about "productive conversations" with Beijing
December 11, 2018 9:17 AM
  • Bernie's Content
What This Long-Term Trendline Says About Apple
The 64-week moving average for AAPL just switched roles to act as resistance
December 11, 2018 7:42 AM
  • SPONSORED CONTENT
The New "Disruptor" Tech Ready to Boom
Early investors stand to reap the rewards as a new technology looks to change everything.
    December 10, 2018 5:03 PM
    • SPONSORED CONTENT
    How to Profit When the Market Closes
    Traders don't need to wait until the opening bell to start raking in massive wins.
      December 10, 2018 8:53 AM
      • Quantitative Analysis
      • Technical Analysis
      Signal Says Take Profits on This Pharma Stock
      The shares are testing a familiar ceiling on the charts
      December 14, 2018 10:40 AM
      • Technical Analysis
      • Indexes and ETFs
      • Editor's Pick
      What to Make of the S&P Death Cross
      It's the index's first death cross in nearly three years
      December 13, 2018 12:54 PM
      • Quantitative Analysis
      2 Tech Stocks That Could Fade Into the New Year
      Tech stocks have been under heavy scrutiny in recent months
      December 12, 2018 12:06 PM
      From Schaeffer's Pro Traders
      Weekly Options Secrets Revealed

      Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


      Partnercenter

      NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

      MORE | MARKETstories

      • SPONSORED CONTENT
      The Shortcut to Earnings Season Profits
      A free tool can help traders bank big this earnings season.
        December 12, 2018 11:17 AM
        • 5-Minute Market Rundown
        Trade Buzz Sparks Roller-Coaster Week For Stocks
        The Dow and S&P 500 are heading toward weekly losses
        December 14, 2018 1:12 PM
        • Buzz Stocks
        Tariff Buzz Gives Ford a Lift
        China announced that it would temporarily halt additional tariffs on U.S.-made autos
        December 14, 2018 11:33 AM
        • SPONSORED CONTENT
        This May Be the 21st Century "Oil Boom"
        U.S. production of lithium is set to increase 1,300% in the next 2 years.
          December 14, 2018 8:11 AM
          • SCHAEFFER'S INVESTMENT RESEARCH
          • 5151 Pfeiffer Rd., Suite 250
          • Cincinnati OH 45242
          • (800) 448-2080 US
          • (513) 589-3800 International
          CONNECT with US
          © 2018 Schaeffer's Investment Research, Inc.
          All Rights Reserved. Unauthorized reproduction of any SIR publication is strictly prohibited.